Nancy Pecen
Psychiatry · Downers Grove, ILNPI 1558314583
Payments from drug & device makers
Across 360 payments — averaging $20.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- Corium, LLC$1K
- Lundbeck LLC$618
- Takeda Pharmaceuticals U.S.A., Inc.$446
- Ironshore Pharmaceuticals Inc.$436
- Tris Pharma Inc$410
- plus $2K from 20 others
What the payments were for
- Food & beverage$7,408100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 102 | $2,423 |
| Corium, LLC | 56 | $1,131 |
| Lundbeck LLC | 34 | $618 |
| Takeda Pharmaceuticals U.S.A., Inc. | 23 | $446 |
| Ironshore Pharmaceuticals Inc. | 19 | $436 |
| Tris Pharma Inc | 17 | $410 |
| Supernus Pharmaceuticals, Inc. | 15 | $351 |
| Otsuka America Pharmaceutical, Inc. | 18 | $312 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 10 | $167 |
| Collegium Pharmaceutical, Inc. | 8 | $159 |
| Vanda Pharmaceuticals Inc. | 9 | $149 |
| Axsome Therapeutics, Inc. | 7 | $130 |
| Alkermes, Inc. | 6 | $110 |
| Johnson & Johnson | 6 | $102 |
| Shire North American Group Inc | 5 | $79 |
| Neurocrine Biosciences, Inc. | 4 | $72 |
| Neos Therapeutics, LP | 5 | $66 |
| Almatica Pharma LLC | 3 | $53 |
| Bausch Health US, LLC | 3 | $43 |
| Adlon Therapeutics L.p. | 2 | $36 |
| Jazz Pharmaceuticals Inc. | 2 | $24 |
| Vertical Pharmaceuticals, LLC | 2 | $24 |
| Noven Therapeutics, LLC | 1 | $19 |
| Sunovion Pharmaceuticals Inc. | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Teva Pharmaceuticals USA, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VRAYLAR$683
- QELBREE$130
- Jornay PM 20mg capsules (Bottle of 100)$125
- QULIPTA$125
- Dyanavel XR$106
How this compares
$7,408 in reported general payments places this provider in the 90th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 62 | $1,976 |
| Venlafaxine Hcl ErVenlafaxine Hcl | 21 | $972 |
| Risperidone | 34 | $616 |
| Duloxetine Hcl | 24 | $443 |
| Fluvoxamine Maleate | 12 | $433 |
| Trazodone Hcl | 31 | $407 |
| Bupropion XlBupropion Hcl | 18 | $393 |
| Mirtazapine | 18 | $379 |
| Lamotrigine | 29 | $372 |
| Buspirone Hcl | 21 | $348 |
| Gabapentin | 28 | $263 |
| Aripiprazole | 18 | $245 |
| Sertraline Hcl | 36 | $239 |
| Quetiapine Fumarate | 36 | $182 |
| Diazepam | 11 | $114 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Almatica Pharma LLCSertraline Hcl | $53 | $23936 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,344 psychiatry providers in Illinois.
Other psychiatry in Downers Grove
- Jeffrey RossNorthbrook$10.8M
- Yuhwen ChowChicago$8.5M
- Mark LermanNorthbrook$4.5M
- Danesh AlamWinfield$2.7M
- John ZajeckaSkokie$2.5M
- Riaz BaberNaperville$2.4M
- Michael GreenbaumLibertyville$2.2M
- Sandeep GaonkarNaperville$1.8M
- Jon GrantChicago$1.4M
- David KempOak Lawn$1.4M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.